Cigna (CI) Cash & Equivalents (2017 - 2026)

Cigna has disclosed Cash & Equivalents across 10 years of filings, most recently posting $7.0 billion for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $7.0 billion, down 15.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 billion (down 15.53% YoY), and the FY2025 annual result was $7.7 billion, up 1.67% from the prior year.
• Cash & Equivalents came in at $7.0 billion for Q1 2026 at Cigna, down from $7.7 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $9.6 billion in Q2 2023 to a low of $4.3 billion in Q2 2025.
• The 5-year median for Cash & Equivalents is $7.1 billion (2022), against an average of $6.9 billion.
• Across the five-year window, Cash & Equivalents surged 116.81% in 2023 and slumped 36.23% in 2025, its largest moves.
• Cigna's Cash & Equivalents stood at $5.9 billion in 2022, then surged by 32.04% to $7.8 billion in 2023, then dropped by 3.48% to $7.6 billion in 2024, then grew by 1.67% to $7.7 billion in 2025, then decreased by 8.29% to $7.0 billion in 2026.
• The last three Cash & Equivalents figures came in at $7.0 billion (Q1 2026), $7.7 billion (Q4 2025), and $6.0 billion (Q3 2025), per Business Quant data.